1 - 10 of 16 articles
The accepted treatment of unprotected left main coronary artery disease is coronary artery bypass surgery (CABG). The approval of drug‐eluting stents (DES) has increasingly led to their off‐label use in this patient population. Currently, the data supporting the safety and efficacy of DES for...
To date, one third of patients with symptomatic aortic stenosis are not operated on because of advanced age, depressed left ventricular function, or comorbidities. Whereas balloon aortic valvuloplasty can be used as a palliative treatment in this population, the hemodynamic and clinical benefits...
Postinfarction ventricular septal defect remains an important complication for myocardial infarction. It is associated with high mortality and morbidity. Despite early surgical closure attempts, mortality remains about 19–49%. Percutaneous approach, especially in high surgical risk patients is a...
Drug‐eluting stents (DES) represent a major advance in percutaneous coronary intervention (PCI). Clinical trials have shown significant reductions in restenosis with both sirolimus‐ and paclitaxel‐eluting stents, with subsequent revascularization rates in the single digit range in most studies....
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.